{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:18:20Z","timestamp":1793697500004,"version":"4.5.1"},"reference-count":113,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009002","name":"Ministry of Education and Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Recognizing the growing global burden of fungal infections, the World Health Organization established a process to develop a priority list of fungal pathogens (FPPL). In this systematic review, we aimed to evaluate the epidemiology and impact of invasive infections caused by Aspergillus fumigatus to inform the first FPPL. The pre-specified criteria of mortality, inpatient care, complications and sequelae, antifungal susceptibility, risk factors, preventability, annual incidence, global distribution, and emergence were used to search for relevant articles between 1 January 2016 and 10 June 2021. Overall, 49 studies were eligible for inclusion. Azole antifungal susceptibility varied according to geographical regions. Voriconazole susceptibility rates of 22.2% were reported from the Netherlands, whereas in Brazil, Korea, India, China, and the UK, voriconazole susceptibility rates were 76%, 94.7%, 96.9%, 98.6%, and 99.7%, respectively. Cross-resistance was common with 85%, 92.8%, and 100% of voriconazole-resistant A. fumigatus isolates also resistant to itraconazole, posaconazole, and isavuconazole, respectively. The incidence of invasive aspergillosis (IA) in patients with acute leukemia was estimated at 5.84\/100 patients. Six-week mortality rates in IA cases ranged from 31% to 36%. Azole resistance and hematological malignancy were poor prognostic factors. Twelve-week mortality rates were significantly higher in voriconazole-resistant than in voriconazole-susceptible IA cases (12\/22 [54.5%] vs. 27\/88 [30.7%]; P\u00a0=\u00a0.035), and hematology patients with IA had significantly higher mortality rates compared with solid-malignancy cases who had IA (65\/217 [30%] vs. 14\/78 [18%]; P\u00a0=\u00a0.04). Carefully designed surveillance studies linking laboratory and clinical data are required to better inform future FPPL.<\/jats:p>","DOI":"10.1093\/mmy\/myad129","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T20:15:25Z","timestamp":1719519325000},"source":"Crossref","is-referenced-by-count":61,"title":["<i>Aspergillus fumigatus<\/i>\u2014a systematic review to inform the World Health Organization priority list of fungal pathogens"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9970-9575","authenticated-orcid":false,"given":"C Orla","family":"Morrissey","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Alfred Health and Monash University , Melbourne, Victoria , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1808-5036","authenticated-orcid":false,"given":"Hannah Y","family":"Kim","sequence":"additional","affiliation":[{"name":"The University of Sydney Infectious Diseases Institute (Sydney ID) , New South Wales , Australia"},{"name":"Faculty of Medicine and Health, School of Pharmacy, The University of Sydney , New South Wales , Australia"},{"name":"Westmead Hospital , Westmead, New South Wales , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5337-1054","authenticated-orcid":false,"given":"Tra-My N","family":"Duong","sequence":"additional","affiliation":[{"name":"The University of Sydney Infectious Diseases Institute (Sydney ID) , New South Wales , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0875-3982","authenticated-orcid":false,"given":"Eric","family":"Moran","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology , East Melbourne, Victoria , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8651-4405","authenticated-orcid":false,"given":"Ana","family":"Alastruey-Izquierdo","sequence":"additional","affiliation":[{"name":"Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III , Majadahonda, Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5626-2251","authenticated-orcid":false,"given":"David W","family":"Denning","sequence":"additional","affiliation":[{"name":"Global Action for Fungal Infections , Geneva , Switzerland"},{"name":"Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester , Manchester , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0019-8638","authenticated-orcid":false,"given":"John R","family":"Perfect","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Health, Duke University School of Medicine , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4867-0014","authenticated-orcid":false,"given":"Marcio","family":"Nucci","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro and Grupo Oncoclinicas , Rio de Janeiro, RJ , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1555-3807","authenticated-orcid":false,"given":"Arunaloke","family":"Chakrabarti","sequence":"additional","affiliation":[{"name":"Doodhadhari Burfani Hospital and Research Institute , Haridwar , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6154-4920","authenticated-orcid":false,"given":"Volker","family":"Rickerts","sequence":"additional","affiliation":[{"name":"Robert Koch Institute Berlin , FG16, Seestrasse 10, 13353 Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2251-8033","authenticated-orcid":false,"given":"Tom M","family":"Chiller","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, GA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3294-5792","authenticated-orcid":false,"given":"Retno","family":"Wahyuningsih","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Faculty of Medicine, Universitas Indonesia , Jakarta , Indonesia"},{"name":"Department of Parasitology, Faculty of Medicine, Universitas Kristen , Jakarta , Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5007-7896","authenticated-orcid":false,"given":"Raph L","family":"Hamers","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit Indonesia, Faculty of Medicine, Universitas Indonesia , Jakarta , Indonesia"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford , Oxford , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7973-6445","authenticated-orcid":false,"given":"Alessandro","family":"Cassini","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Lausanne University Hospital , Lausanne , Switzerland"},{"name":"Public Health Department , Canton of Vaud, Lausanne , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2496-6048","authenticated-orcid":false,"given":"Valeria","family":"Gigante","sequence":"additional","affiliation":[{"name":"AMR Division, World Health Organization , Geneva , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2358-0522","authenticated-orcid":false,"given":"Hatim","family":"Sati","sequence":"additional","affiliation":[{"name":"AMR Division, World Health Organization , Geneva , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6703-0288","authenticated-orcid":false,"given":"Jan-Willem","family":"Alffenaar","sequence":"additional","affiliation":[{"name":"The University of Sydney Infectious Diseases Institute (Sydney ID) , New South Wales , Australia"},{"name":"Faculty of Medicine and Health, School of Pharmacy, The University of Sydney , New South Wales , Australia"},{"name":"Westmead Hospital , Westmead, New South Wales , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1978-1559","authenticated-orcid":false,"given":"Justin","family":"Beardsley","sequence":"additional","affiliation":[{"name":"The University of Sydney Infectious Diseases Institute (Sydney ID) , New South Wales , Australia"},{"name":"Westmead Institute for Medical Research , Westmead, New South Wales , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"issue":"suppl 1","key":"2024062717015652300_bib1","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1080\/13693780400025179","article-title":"The invasive and saprophytic syndromes due to Aspergillus spp","volume":"43","author":"Hope","year":"2005","journal-title":"Med Mycol"},{"key":"2024062717015652300_bib2","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.bbmt.2007.08.049","article-title":"Higher risk of Cytomegalovirus and Aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease","volume":"13","author":"van\u00a0Burik","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024062717015652300_bib3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2024062717015652300_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13054-015-0905-x","article-title":"Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients","volume":"19","author":"Eigl","year":"2015","journal-title":"Crit Care"},{"key":"2024062717015652300_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/mmy\/myx011","article-title":"Invasive aspergillosis in patients with underlying liver cirrhosis: a prospective cohort study","volume":"55","author":"Prattes","year":"2017","journal-title":"Med Mycol"},{"key":"2024062717015652300_bib6","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3201\/eid2704.204895","article-title":"COVID-19-associated pulmonary aspergillosis, March\u2013August 2020","volume":"27","author":"Salmanton-Garc\u00eda","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2024062717015652300_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19-associated pulmonary aspergillosis","volume":"202","author":"van\u00a0Arkel","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024062717015652300_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13613-020-00686-4","article-title":"COVID-19-associated invasive pulmonary aspergillosis","volume":"10","author":"Rutsaert","year":"2020","journal-title":"Ann Intensive Care"},{"key":"2024062717015652300_bib9","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.cmi.2020.07.010","article-title":"Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients","volume":"26","author":"Lamoth","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2024062717015652300_bib10","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19","volume":"8","author":"Alanio","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024062717015652300_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/jof6030105","article-title":"Is the COVID-19 Pandemic a good time to include Aspergillus molecular detection to categorize aspergillosis in ICU patients? A monocentric experience","volume":"6","author":"Gangneux","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2024062717015652300_bib12","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/cid\/ciaa010","article-title":"Influenza-associated pulmonary aspergillosis: a local or global lethal combination?","volume":"71","author":"Rijnders","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024062717015652300_bib13","doi-asserted-by":"crossref","first-page":"e00140","DOI":"10.1128\/CMR.00140-18","article-title":"Aspergillus fumigatus and aspergillosis in 2019","volume":"33","author":"Latg\u00e9","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"suppl 2","key":"2024062717015652300_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/myc.12224","article-title":"The role of surgical debridement in different clinical manifestations of invasive aspergillosis","volume":"57","author":"Reischies","year":"2014","journal-title":"Mycoses"},{"key":"2024062717015652300_bib15","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.12998\/wjcc.v6.i16.1155","article-title":"Renal aspergillosis in a liver transplant patient: a case report and review of literature","volume":"6","author":"Smolovic","year":"2018","journal-title":"World J Clin Cases"},{"key":"2024062717015652300_bib16","doi-asserted-by":"crossref","first-page":"omz147","DOI":"10.1093\/omcr\/omz147","article-title":"Native valve fungal endocarditis caused by Aspergillus fumigatus: management dilemma","volume":"2020","author":"Aldosari","year":"2020","journal-title":"Oxf Med Case Reports"},{"key":"2024062717015652300_bib17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3390\/pathogens10060643","article-title":"Aspergillus genus and its various human superficial and cutaneous features","volume":"10","author":"Merad","year":"2021","journal-title":"Pathogens"},{"key":"2024062717015652300_bib18","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/jac\/dkz258","article-title":"Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients","volume":"74","author":"Resendiz-Sharpe","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2024062717015652300_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2024062717015652300_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41579-023-00861-x","article-title":"The WHO fungal priority pathogens list as a game-changer","volume":"21","author":"Fisher","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"2024062717015652300_bib21","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2024062717015652300_bib22","doi-asserted-by":"crossref","first-page":"D136","DOI":"10.1093\/nar\/gkr1178","article-title":"The NCBI Taxonomy database","volume":"40","author":"Federhen","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2024062717015652300_bib23","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2024062717015652300_bib24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","article-title":"Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity","volume":"66","author":"Kim","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"2024062717015652300_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02264-17","article-title":"Emergence of azole-resistant Aspergillus fumigatus from immunocompromised hosts in India","volume":"62","author":"Dabas","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2024062717015652300_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2024062717015652300_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/cid\/cix297","article-title":"Changes in In vitro susceptibility patterns of Aspergillus to triazoles and correlation with aspergillosis outcome in a Tertiary Care cancer center, 1999\u20132015","volume":"65","author":"Heo","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2024062717015652300_bib28","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciy859","article-title":"Voriconazole resistance and mortality in invasive aspergillosis: a multicenter retrospective cohort study","volume":"68","author":"Lestrade","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024062717015652300_bib29","doi-asserted-by":"crossref","first-page":"e02023","DOI":"10.1128\/JCM.02023-18","article-title":"Epidemiology and antifungal susceptibility profile of Aspergillus species: comparison between environmental and clinical isolates from patients with hematologic malignancies","volume":"57","author":"Cho","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2024062717015652300_bib30","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/jac\/dkx527","article-title":"Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study","volume":"73","author":"Lestrade","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2024062717015652300_bib31","first-page":"3456","article-title":"Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013","volume":"21","author":"van\u00a0Paassen","year":"2016","journal-title":"Euro Surveill"},{"key":"2024062717015652300_bib32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1089\/sur.2018.045","article-title":"Invasive pulmonary aspergillosis: risks for acquisition and death in a community hospital","volume":"19","author":"Lane","year":"2018","journal-title":"Surg Infect (Larchmt)"},{"key":"2024062717015652300_bib33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2217\/cer-2020-0019","article-title":"US database study: burden and healthcare resource utilization in adults with systemic endemic mycoses and aspergillosis","volume":"9","author":"Forsythe","year":"2020","journal-title":"J Comp Eff Res"},{"key":"2024062717015652300_bib34","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.3389\/fmicb.2018.02234","article-title":"Surveillance for azole-resistant Aspergillus fumigatus in a Centralized Diagnostic Mycology Service, London, United Kingdom, 1998\u20132017","volume":"9","author":"Abdolrasouli","year":"2018","journal-title":"Front Microbiol"},{"key":"2024062717015652300_bib35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ijantimicag.2018.08.004","article-title":"High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre","volume":"52","author":"Abdolrasouli","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"2024062717015652300_bib36","doi-asserted-by":"crossref","first-page":"e00358","DOI":"10.1128\/AAC.00358-18","article-title":"Molecular identification and susceptibility testing of molds isolated in a prospective surveillance of triazole resistance in Spain (FILPOP2 Study)","volume":"62","author":"Alastruey-Izquierdo","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2024062717015652300_bib37","doi-asserted-by":"crossref","first-page":"570.e1","DOI":"10.1016\/j.cmi.2016.04.001","article-title":"Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes","volume":"22","author":"Jensen","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2024062717015652300_bib38","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2147\/IDR.S170952","article-title":"Widespread amphotericin B-resistant strains of Aspergillus fumigatus in Hamilton, Canada","volume":"11","author":"Ashu","year":"2018","journal-title":"Infect Drug Resist"},{"key":"2024062717015652300_bib39","doi-asserted-by":"crossref","first-page":"e02136","DOI":"10.1128\/JCM.02136-20","article-title":"COVID-19-associated invasive aspergillosis: data from the UK National Mycology Reference Laboratory","volume":"59","author":"Borman","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2024062717015652300_bib40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jac\/dkx354","article-title":"Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs","volume":"73","author":"Buil","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2024062717015652300_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/mmy\/myz032","article-title":"Azole resistance among clinical isolates of Aspergillus fumigatus in Lima-Peru","volume":"58","author":"Bustamante","year":"2020","journal-title":"Med Mycol"},{"key":"2024062717015652300_bib42","doi-asserted-by":"crossref","first-page":"e00906","DOI":"10.1128\/AAC.00906-17","article-title":"Monitoring antifungal resistance in a global collection of invasive yeasts and molds: application of CLSI epidemiological cutoff values and whole-genome sequencing analysis for detection of azole resistance in Candida albicans","volume":"61","author":"Castanheira","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2024062717015652300_bib43","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1128\/AAC.01005-16","article-title":"Epidemiology and molecular characterizations of azole resistance in clinical and environmental Aspergillus fumigatus isolates from China","volume":"60","author":"Chen","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2024062717015652300_bib44","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1038\/emi.2017.97","article-title":"Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China","volume":"6","author":"Deng","year":"2017","journal-title":"Emerg Microbes Infect"},{"key":"2024062717015652300_bib45","doi-asserted-by":"crossref","first-page":"e02045","DOI":"10.1128\/AAC.02045-16","article-title":"Activity of a long-acting echinocandin (CD101) and seven comparator antifungal agents tested against a global collection of contemporary invasive fungal isolates in the SENTRY 2014 antifungal surveillance program","volume":"61","author":"Pfaller","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2024062717015652300_bib46","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3389\/fmicb.2018.01656","article-title":"Aspergillus species and antifungals susceptibility in clinical setting in the north of Portugal: cryptic species and emerging azoles resistance in A. fumigatus","volume":"9","author":"Pinto","year":"2018","journal-title":"Front Microbiol"},{"key":"2024062717015652300_bib47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcf.2016.06.006","article-title":"Triazole resistance in Aspergillus fumigatus isolates from patients with cystic fibrosis in Italy","volume":"16","author":"Prigitano","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2024062717015652300_bib48","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/myc.12759","article-title":"Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates","volume":"61","author":"Reichert-Lima","year":"2018","journal-title":"Mycoses"},{"key":"2024062717015652300_bib49","doi-asserted-by":"crossref","first-page":"e01916","DOI":"10.1128\/AAC.01916-17","article-title":"Posaconazole MIC distributions for Aspergillus fumigatus species complex by four methods: impact of cyp51A mutations on estimation of epidemiological cutoff values","volume":"62","author":"Espinel-Ingroff","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2024062717015652300_bib50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijantimicag.2016.10.019","article-title":"Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA study","volume":"49","author":"Koehler","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"2024062717015652300_bib51","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s15010-018-1170-0","article-title":"A nationwide passive surveillance on fungal infections shows a low burden of azole resistance in molds and yeasts in Tyrol","volume":"46","author":"Lass-Fl\u00f6rl","year":"2018","journal-title":"Austria Infection"},{"key":"2024062717015652300_bib52","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dkz144","article-title":"One year prospective survey of azole resistance in Aspergillus fumigatus at a French cystic fibrosis reference centre: prevalence and mechanisms of resistance","volume":"74","author":"Lavergne","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2024062717015652300_bib53","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3201\/eid2607.200088","article-title":"Paradoxal trends in azole-resistant Aspergillus fumigatus in a National Multicenter Surveillance Program, the Netherlands, 2013\u20132018","volume":"26","author":"Lestrade","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2024062717015652300_bib54","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3201\/eid2604.190840","article-title":"Multicenter study of azole-resistant Aspergillus fumigatus clinical isolates,\u00a0Taiwan","volume":"26","author":"Wu","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2024062717015652300_bib55","doi-asserted-by":"crossref","first-page":"115007","DOI":"10.1016\/j.diagmicrobio.2020.115007","article-title":"In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017\u20132018","volume":"97","author":"Messer","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2024062717015652300_bib56","first-page":"994","article-title":"Isolation and characterization of clinical triazole resistance Aspergillus fumigatus in Iran","volume":"47","author":"Mohammadi","year":"2018","journal-title":"Iran J Public Health"},{"key":"2024062717015652300_bib57","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1099\/jmm.0.000255","article-title":"High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?","volume":"65","author":"Nabili","year":"2016","journal-title":"J Med Microbiol"},{"key":"2024062717015652300_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/mmy\/myx012","article-title":"Detection of polish clinical Aspergillus fumigatus isolates resistant to triazoles","volume":"56","author":"Nawrot","year":"2018","journal-title":"Med Mycol"},{"key":"2024062717015652300_bib59","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5604\/01.3001.0013.0511","article-title":"Activity of isavuconazole and other triazole derivatives against clinical isolates of Aspergillus fumigatus","volume":"73","author":"Nawrot","year":"2019","journal-title":"Postepy Hig Med Dosw"},{"key":"2024062717015652300_bib60","doi-asserted-by":"crossref","first-page":"e00608","DOI":"10.1128\/AAC.00608-17","article-title":"Triazole resistance is still not emerging in Aspergillus fumigatus isolates causing invasive aspergillosis in Brazilian patients","volume":"61","author":"Negri","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2024062717015652300_bib61","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkz534","article-title":"Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013","volume":"75","author":"Parent-Michaud","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2024062717015652300_bib62","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/jac\/dky147","article-title":"Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany","volume":"73","author":"Seufert","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2024062717015652300_bib63","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/mmy\/myaa052","article-title":"High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance","volume":"59","author":"Takeda","year":"2021","journal-title":"Med Mycol"},{"key":"2024062717015652300_bib64","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1093\/jac\/dky187","article-title":"Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates","volume":"73","author":"Talbot","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2024062717015652300_bib65","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/mmy\/myz003","article-title":"Prospective multicenter surveillance of clinically isolated Aspergillus species revealed azole-resistant Aspergillus fumigatus isolates with TR34\/L98H mutation in the Kyoto and Shiga regions of Japan","volume":"57","author":"Tsuchido","year":"2019","journal-title":"Med Mycol"},{"key":"2024062717015652300_bib66","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4103\/0366-6999.201609","article-title":"Triazole resistance in Aspergillus fumigatus clinical isolates obtained in Nanjing, China","volume":"130","author":"Zhang","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"2024062717015652300_bib67","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jhin.2019.09.020","article-title":"Invasive pulmonary aspergillosis: comparative analysis in cancer patients with underlying haematologic malignancies versus solid tumours","volume":"104","author":"Dib","year":"2020","journal-title":"J Hosp Infect"},{"key":"2024062717015652300_bib68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/myc.12440","article-title":"Diagnosis and management of aspergillosis in the Netherlands: a national survey","volume":"59","author":"Lestrade","year":"2016","journal-title":"Mycoses"},{"key":"2024062717015652300_bib69","article-title":"WHO fungal priority pathogen list to guide research, development and public health action","year":"2022"},{"key":"2024062717015652300_bib70","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/pds.4255","article-title":"MCDA swing weighting and discrete choice experiments for elicitation of patient benefit-risk preferences: a critical assessment","volume":"26","author":"Tervonen","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2024062717015652300_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jval.2015.12.003","article-title":"Multiple criteria decision analysis for health care decision making\u2014an introduction: report 1 of the ISPOR MCDA Emerging Good Practices Task Force","volume":"19","author":"Thokala","year":"2016","journal-title":"Value Health"},{"key":"2024062717015652300_bib72","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"2024062717015652300_bib73","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","article-title":"Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial","volume":"397","author":"Maertens","year":"2021","journal-title":"Lancet"},{"key":"2024062717015652300_bib74","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1086\/592255","article-title":"Factors associated with overall and attributable mortality in invasive aspergillosis","volume":"47","author":"Nivoix","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2024062717015652300_bib75","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0003-4975(97)00858-8","article-title":"Surgical management of invasive pulmonary aspergillosis in neutropenic patients","volume":"64","author":"Bernard","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"2024062717015652300_bib76","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12663-018-01182-w","article-title":"Fungal rhinosinusitis: unravelling the disease spectrum","volume":"18","author":"Singh","year":"2019","journal-title":"J Maxillofac Oral Surg"},{"key":"2024062717015652300_bib77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3324\/haematol.2010.030825","article-title":"Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study","volume":"96","author":"Even","year":"2011","journal-title":"Haematologica"},{"key":"2024062717015652300_bib78","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/AAC.01423-10","article-title":"Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach","volume":"55","author":"Ananda-Rajah","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2024062717015652300_bib79","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","author":"van\u00a0der\u00a0Linden","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2024062717015652300_bib80","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2024062717015652300_bib81","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"2024062717015652300_bib82","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s40265-017-0714-4","article-title":"Triazole resistance in Aspergillus species: an emerging problem","volume":"77","author":"Garcia-Rubio","year":"2017","journal-title":"Drugs"},{"key":"2024062717015652300_bib83","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/jac\/dkt075","article-title":"The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus","volume":"68","author":"Fraczek","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2024062717015652300_bib84","doi-asserted-by":"crossref","first-page":"e00437","DOI":"10.1128\/mBio.00437-19","article-title":"Mutations in hmg1, challenging the paradigm of clinical triazole resistance in Aspergillus fumigatus","volume":"10","author":"Rybak","year":"2019","journal-title":"mBio"},{"key":"2024062717015652300_bib85","doi-asserted-by":"crossref","first-page":"e50034","DOI":"10.1371\/journal.pone.0050034","article-title":"Discovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing","volume":"7","author":"Camps","year":"2012","journal-title":"PLoS One"},{"key":"2024062717015652300_bib86","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1128\/JCM.02221-09","article-title":"Rapid diagnosis of azole-resistant aspergillosis by direct PCR using tissue specimens","volume":"48","author":"van\u00a0der\u00a0Linden","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2024062717015652300_bib87","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease","volume":"52","author":"Denning","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2024062717015652300_bib88","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/jac\/dkt071","article-title":"Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases","volume":"68","author":"Zhao","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2024062717015652300_bib89","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/JCM.03216-14","article-title":"Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid","volume":"53","author":"Chong","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2024062717015652300_bib90","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/jac\/dkw323","article-title":"PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay\u00ae in 201 patients with haematological disease suspected for invasive aspergillosis","volume":"71","author":"Chong","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2024062717015652300_bib91","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1128\/JCM.01032-17","article-title":"Molecular diagnosis of invasive aspergillosis and detection of azole resistance by a newly commercialized PCR kit","volume":"55","author":"Dannaoui","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2024062717015652300_bib92","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1128\/JCM.00520-17","article-title":"Culture-based methods and molecular tools for azole-resistant Aspergillus fumigatus detection in a Belgian University Hospital","volume":"55","author":"Montesinos","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2024062717015652300_bib93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/myc.12702","article-title":"PCR-based detection of Aspergillus fumigatus and absence of azole resistance due to TR(34) \/L98H in a french multicenter cohort of 137 patients with fungal rhinosinusitis","volume":"61","author":"Morio","year":"2018","journal-title":"Mycoses"},{"key":"2024062717015652300_bib94","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/jac\/dkx262","article-title":"Detection of azole-susceptible and azole-resistant Aspergillus coinfection by cyp51A PCR amplicon melting curve analysis","volume":"72","author":"Schauwvlieghe","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2024062717015652300_bib95","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1128\/JCM.00667-15","article-title":"Analytical and clinical evaluation of the PathoNostics AsperGenius Assay for detection of invasive aspergillosis and resistance to azole antifungal drugs during testing of serum samples","volume":"53","author":"White","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2024062717015652300_bib96","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/JCM.00411-17","article-title":"Analytical and clinical evaluation of the PathoNostics AsperGenius assay for detection of invasive aspergillosis and resistance to azole antifungal drugs directly from plasma samples","volume":"55","author":"White","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2024062717015652300_bib97","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JCM.00905-15","article-title":"Clinical performance of Aspergillus PCR for testing serum and plasma: a study by the European Aspergillus PCR Initiative","volume":"53","author":"White","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2024062717015652300_bib98","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1128\/JCM.43.2.906-908.2005","article-title":"Detection of Aspergillus fumigatus and a mutation that confers reduced susceptibility to itraconazole and posaconazole by real-time PCR and pyrosequencing","volume":"43","author":"Trama","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2024062717015652300_bib99","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1128\/AAC.05902-11","article-title":"Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients","volume":"56","author":"Spiess","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2024062717015652300_bib100","doi-asserted-by":"crossref","first-page":"e103113","DOI":"10.1371\/journal.pone.0103113","article-title":"Incidence of Cyp51 A key mutations in Aspergillus fumigatus\u2014a study on primary clinical samples of immunocompromised patients in the period of 1995\u20132013","volume":"9","author":"Spiess","year":"2014","journal-title":"PLoS One"},{"key":"2024062717015652300_bib101","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3389\/fmicb.2016.01164","article-title":"Direct molecular diagnosis of aspergillosis and CYP51A profiling from respiratory samples of French patients","volume":"7","author":"Zhao","year":"2016","journal-title":"Front Microbiol"},{"key":"2024062717015652300_bib102","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/cid\/ciy175","article-title":"Serious infections in patients receiving Ibrutinib for treatment of lymphoid cancer","volume":"67","author":"Varughese","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024062717015652300_bib103","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1182\/blood-2017-11-818286","article-title":"Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib","volume":"131","author":"Ghez","year":"2018","journal-title":"Blood"},{"key":"2024062717015652300_bib104","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ccell.2017.04.012","article-title":"Inhibition of B cell receptor signaling by Ibrutinib in primary CNS lymphoma","volume":"31","author":"Lionakis","year":"2017","journal-title":"Cancer Cell"},{"key":"2024062717015652300_bib105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2024062717015652300_bib106","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/cid\/ciab223","article-title":"Coronavirus Disease 2019-associated pulmonary aspergillosis in mechanically ventilated patients","volume":"74","author":"Permpalung","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2024062717015652300_bib107","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024062717015652300_bib108","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-021-03753-9","article-title":"Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study","volume":"25","author":"Hatzl","year":"2021","journal-title":"Crit Care"},{"key":"2024062717015652300_bib109","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/jof8020097","article-title":"COVID-19-associated pulmonary aspergillosis in a tertiary hospital","volume":"8","author":"Marta","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2024062717015652300_bib110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1479972318761654","article-title":"High burden of Aspergillus fumigatus infection among chronic respiratory diseases","volume":"15","author":"Fukuda","year":"2018","journal-title":"Chron Respir Dis"},{"key":"2024062717015652300_bib111","doi-asserted-by":"crossref","first-page":"613774","DOI":"10.3389\/fcimb.2020.613774","article-title":"Azole resistance in Aspergillus fumigatus: a five-year follow up experience in a tertiary hospital with a special focus on cystic fibrosis","volume":"10","author":"Guegan","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"2024062717015652300_bib112","doi-asserted-by":"crossref","first-page":"1091.e1","DOI":"10.1016\/j.cmi.2019.12.009","article-title":"Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study","volume":"26","author":"Lee","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2024062717015652300_bib113","first-page":"9899","article-title":"Anti-fungal activity of different drugs against Aspergillus fumigatus infection","volume":"11","author":"Sui","year":"2018","journal-title":"Int J Clin Exp Med"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/62\/6\/myad129\/58350528\/myad129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/62\/6\/myad129\/58350528\/myad129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T20:16:28Z","timestamp":1719519388000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myad129\/7700347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":113,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,27]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myad129","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,6]]},"article-number":"myad129"}}